Potential of antibodies to TNF-α, IL-1RA, TNF-α soluble receptors and anti-bradykinin have also tested [39] but it has been observed that treatment with such TLR inhibitors interfere with innate immunity of host against infection and consequently increasing the risk of shock and mortality [39], [40], [41]. The gene discussed is TNF; the disease is infection.